Ivermectin, a medication traditionally used to treat parasitic infections, has shown potential as a cancer treatment due to its ability to induce programmed cell death (apoptosis) in cancer cells. Research has demonstrated that ivermectin can interfere with multiple cellular signaling pathways involved in cancer development and progression, leading to the death of cancer cells. Ivermectin has been shown to be effective in treating a variety of cancers, including breast, lung, and prostate cancer, by inhibiting cancer cell growth and spread.